vs

Side-by-side financial comparison of Amarin Corp plc (AMRN) and Montauk Renewables, Inc. (MNTK). Click either name above to swap in a different company.

Amarin Corp plc is the larger business by last-quarter revenue ($45.1M vs $43.4M, roughly 1.0× Montauk Renewables, Inc.). Montauk Renewables, Inc. runs the higher net margin — 5.7% vs -23.3%, a 29.0% gap on every dollar of revenue. On growth, Montauk Renewables, Inc. posted the faster year-over-year revenue change (56.7% vs 7.0%). Over the past eight quarters, Montauk Renewables, Inc.'s revenue compounded faster (5.8% CAGR vs -18.3%).

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

Montauk Renewables, Inc. is a US-based renewable energy firm specializing in capturing and converting biogenic methane from landfills and agricultural waste into renewable natural gas (RNG) and low-carbon electricity. It serves utility, commercial, and industrial customers across North America, with operations focused on advancing decarbonization and sustainable energy transition goals.

AMRN vs MNTK — Head-to-Head

Bigger by revenue
AMRN
AMRN
1.0× larger
AMRN
$45.1M
$43.4M
MNTK
Growing faster (revenue YoY)
MNTK
MNTK
+49.7% gap
MNTK
56.7%
7.0%
AMRN
Higher net margin
MNTK
MNTK
29.0% more per $
MNTK
5.7%
-23.3%
AMRN
Faster 2-yr revenue CAGR
MNTK
MNTK
Annualised
MNTK
5.8%
-18.3%
AMRN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AMRN
AMRN
MNTK
MNTK
Revenue
$45.1M
$43.4M
Net Profit
$-10.5M
$2.5M
Gross Margin
Operating Margin
35.5%
-3.8%
Net Margin
-23.3%
5.7%
Revenue YoY
7.0%
56.7%
Net Profit YoY
33.0%
129.5%
EPS (diluted)
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRN
AMRN
MNTK
MNTK
Q1 26
$45.1M
Q4 25
$49.2M
$43.4M
Q3 25
$49.7M
$45.3M
Q2 25
$72.7M
$45.1M
Q1 25
$42.0M
$42.6M
Q4 24
$62.3M
$27.7M
Q3 24
$42.3M
$65.9M
Q2 24
$67.5M
$43.3M
Net Profit
AMRN
AMRN
MNTK
MNTK
Q1 26
$-10.5M
Q4 25
$-1.2M
$2.5M
Q3 25
$-7.7M
$5.2M
Q2 25
$-14.1M
$-5.5M
Q1 25
$-15.7M
$-464.0K
Q4 24
$-48.6M
$-8.5M
Q3 24
$-25.1M
$17.0M
Q2 24
$1.5M
$-712.0K
Gross Margin
AMRN
AMRN
MNTK
MNTK
Q1 26
Q4 25
47.1%
Q3 25
44.7%
Q2 25
69.2%
Q1 25
59.8%
Q4 24
-15.4%
Q3 24
38.5%
43.8%
Q2 24
63.4%
15.6%
Operating Margin
AMRN
AMRN
MNTK
MNTK
Q1 26
35.5%
Q4 25
-12.9%
-3.8%
Q3 25
-22.4%
9.8%
Q2 25
-22.0%
-5.2%
Q1 25
-39.9%
1.0%
Q4 24
-84.3%
-35.5%
Q3 24
-59.5%
34.4%
Q2 24
-0.8%
2.0%
Net Margin
AMRN
AMRN
MNTK
MNTK
Q1 26
-23.3%
Q4 25
-2.5%
5.7%
Q3 25
-15.6%
11.5%
Q2 25
-19.4%
-12.2%
Q1 25
-37.4%
-1.1%
Q4 24
-78.0%
-30.5%
Q3 24
-59.4%
25.9%
Q2 24
2.3%
-1.6%
EPS (diluted)
AMRN
AMRN
MNTK
MNTK
Q1 26
Q4 25
$0.00
$0.01
Q3 25
$-0.02
$0.04
Q2 25
$-0.03
$-0.04
Q1 25
$-0.04
$0.00
Q4 24
$-0.12
$-0.05
Q3 24
$-0.06
$0.12
Q2 24
$0.00
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRN
AMRN
MNTK
MNTK
Cash + ST InvestmentsLiquidity on hand
$307.8M
$23.8M
Total DebtLower is stronger
$126.0M
Stockholders' EquityBook value
$263.1M
Total Assets
$645.8M
$435.5M
Debt / EquityLower = less leverage
0.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRN
AMRN
MNTK
MNTK
Q1 26
$307.8M
Q4 25
$302.6M
$23.8M
Q3 25
$286.6M
$6.8M
Q2 25
$298.7M
$29.1M
Q1 25
$281.8M
$40.1M
Q4 24
$294.2M
$45.6M
Q3 24
$305.7M
$55.0M
Q2 24
$306.7M
$42.3M
Total Debt
AMRN
AMRN
MNTK
MNTK
Q1 26
Q4 25
$126.0M
Q3 25
$54.9M
Q2 25
$57.8M
Q1 25
$40.8M
Q4 24
$43.8M
Q3 24
$46.7M
Q2 24
$49.7M
Stockholders' Equity
AMRN
AMRN
MNTK
MNTK
Q1 26
Q4 25
$459.3M
$263.1M
Q3 25
$458.9M
$260.7M
Q2 25
$464.9M
$254.7M
Q1 25
$473.7M
$258.2M
Q4 24
$486.2M
$257.4M
Q3 24
$531.4M
$275.3M
Q2 24
$551.9M
$255.3M
Total Assets
AMRN
AMRN
MNTK
MNTK
Q1 26
$645.8M
Q4 25
$670.8M
$435.5M
Q3 25
$659.8M
$383.3M
Q2 25
$670.1M
$382.5M
Q1 25
$655.7M
$354.2M
Q4 24
$685.3M
$349.0M
Q3 24
$750.6M
$374.1M
Q2 24
$799.9M
$362.0M
Debt / Equity
AMRN
AMRN
MNTK
MNTK
Q1 26
Q4 25
0.48×
Q3 25
0.21×
Q2 25
0.23×
Q1 25
0.16×
Q4 24
0.17×
Q3 24
0.17×
Q2 24
0.19×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRN
AMRN
MNTK
MNTK
Operating Cash FlowLast quarter
$337.0K
Free Cash FlowOCF − Capex
$-41.1M
FCF MarginFCF / Revenue
-94.7%
Capex IntensityCapex / Revenue
95.5%
Cash ConversionOCF / Net Profit
0.14×
TTM Free Cash FlowTrailing 4 quarters
$-86.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRN
AMRN
MNTK
MNTK
Q1 26
Q4 25
$15.3M
$337.0K
Q3 25
$-12.7M
$12.7M
Q2 25
$16.6M
$8.2M
Q1 25
$-12.5M
$9.1M
Q4 24
$-13.3M
$724.0K
Q3 24
$-2.4M
$28.6M
Q2 24
$-2.7M
$193.0K
Free Cash Flow
AMRN
AMRN
MNTK
MNTK
Q1 26
Q4 25
$-41.1M
Q3 25
$-17.2M
Q2 25
$-25.5M
Q1 25
$-2.5M
Q4 24
$-8.3M
Q3 24
$16.0M
Q2 24
$-18.6M
FCF Margin
AMRN
AMRN
MNTK
MNTK
Q1 26
Q4 25
-94.7%
Q3 25
-37.9%
Q2 25
-56.4%
Q1 25
-5.8%
Q4 24
-29.8%
Q3 24
24.3%
Q2 24
-42.9%
Capex Intensity
AMRN
AMRN
MNTK
MNTK
Q1 26
Q4 25
95.5%
Q3 25
65.9%
Q2 25
74.6%
Q1 25
27.3%
Q4 24
32.5%
Q3 24
19.1%
Q2 24
43.3%
Cash Conversion
AMRN
AMRN
MNTK
MNTK
Q1 26
Q4 25
0.14×
Q3 25
2.43×
Q2 25
Q1 25
Q4 24
Q3 24
1.68×
Q2 24
-1.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

MNTK
MNTK

Natural Gas Environmental Attributes$28.1M65%
Natural Gas Commodity$10.7M25%
Electric Commodity$2.7M6%
Electric Environmental Attributes$2.0M5%

Related Comparisons